News
Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...
Researchers at the Salk Institute have used CRISPR to uncover hidden microproteins that control fat cell growth and lipid ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...
Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...
Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...
I f you're a FuturHealth member, you'll now have a free membership to Apple Fitness Plus as part of your program. It's Apple Fitness Plus’s first direct integration with a personalized GLP-1 weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results